This protocol is judged by an institutional critique board, an impartial group that assessments any scientific trials involving individuals. If a review includes a Agenda I drug, when the board approves the protocol as ethical, the researchers really have to make an application for an investigational new drug (IND) variety through the FDA.Weiser ur